GM allogeneic healthy donor T-cells gene edited ex vivo using CRISPR/Cas9 to insert chimeric antigen receptor (CAR) genes targeting cancer-specific antigens: CD19 (CTX110), BCMA (CTX120) and CD70 (CTX130). This evidence concerns the gene TNFRSF17 and cancer.